184 related articles for article (PubMed ID: 20098353)
1. Urinary soluble HLA-DR is a potential biomarker for acute renal transplant rejection.
Ting YT; Coates PT; Marti HP; Dunn AC; Parker RM; Pickering JW; Jack RW; Kemp RA; Walker RJ; McLellan AD
Transplantation; 2010 May; 89(9):1071-8. PubMed ID: 20098353
[TBL] [Abstract][Full Text] [Related]
2. Urinary HLA-DR and CD54 expression--indicators for inflammatory activity in decoy cell shedding patients.
Kim SH; Ahn HJ; Kim YS; Kim SI; Kim HS; Jeong HJ
Nephrol Dial Transplant; 2006 Sep; 21(9):2601-6. PubMed ID: 16837510
[TBL] [Abstract][Full Text] [Related]
3. Activated cells in urine and monocyte chemotactic peptide-1 (MCP-1)--sensitive rejection markers in renal graft recipients.
Dubiński B; Boratyńska M; Kopeć W; Szyber P; Patrzałek D; Klinger M
Transpl Immunol; 2008 Jan; 18(3):203-7. PubMed ID: 18047927
[TBL] [Abstract][Full Text] [Related]
4. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional profiles in urine during acute rejection, bacteriuria, CMV infection and stable graft function after renal transplantation.
Øzbay A; Tørring C; Olsen R; Carstens J
Scand J Immunol; 2009 Apr; 69(4):357-65. PubMed ID: 19284501
[TBL] [Abstract][Full Text] [Related]
6. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine.
Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
Nephrology (Carlton); 2008 Feb; 13(1):73-9. PubMed ID: 18199108
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine.
Hu H; Kwun J; Aizenstein BD; Knechtle SJ
Transplantation; 2009 Jun; 87(12):1814-20. PubMed ID: 19543058
[TBL] [Abstract][Full Text] [Related]
8. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
[TBL] [Abstract][Full Text] [Related]
9. Increased concentration of soluble human leukocyte antigen class I levels in the bronchoalveolar lavage of human pulmonary allografts.
Rizzo M; Sundaresan S; Lynch J; Trulock EP; Cooper J; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 1997 Nov; 16(11):1135-40. PubMed ID: 9402513
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection.
Pelzl S; Opelz G; Daniel V; Wiesel M; Süsal C
Transplantation; 2003 Feb; 75(3):421-3. PubMed ID: 12589170
[TBL] [Abstract][Full Text] [Related]
11. Use of PCR and PCR-SSP for detection of urinary donor-origin DNA in renal transplant recipients with acute rejection.
Zhang Z; Ohkohchi N; Okazaki H; Guo Y
Chin Med J (Engl); 2003 Feb; 116(2):191-4. PubMed ID: 12775227
[TBL] [Abstract][Full Text] [Related]
12. [Dynamic monitoring of serum soluble HLA class I antigens in renal transplant recipients].
Xu J; Cao Q; Wu D; Ma J; Yu L
Zhonghua Wai Ke Za Zhi; 1999 Nov; 37(11):657-9. PubMed ID: 11829918
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR class II and ICAM-1 expression on tubular cells taken by fine-needle aspiration biopsy in renal allograft dysfunction.
Gonzalez-Posada JM; Garcia-Castro MC; Tamajon LP; Torres A; Hernandez D; Losada M; Maceira B; Salido E
Nephrol Dial Transplant; 1996 Jan; 11(1):148-52. PubMed ID: 8649624
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-linked immunosorbent assay for human leukocyte antigen antibody detection and urine protein test recommended for follow-up monitoring after renal transplantation.
Kobayashi T; Katayama A; Kohara S; Nagasaka T; Goto N; Ueki T; Uchida K; Nakao A
Transplantation; 2008 Jun; 85(11):1595-600. PubMed ID: 18551065
[TBL] [Abstract][Full Text] [Related]
15. Soluble human leukocyte antigen: a diagnostic indicator of rheumatoid arthritis?
Hayman MW; van Beijnen MT; Stamp LK; Spellerberg MB; O'Donnell JL
J Immunol Methods; 2006 Aug; 315(1-2):19-26. PubMed ID: 16893550
[TBL] [Abstract][Full Text] [Related]
16. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
17. Immunocytological urinalysis and monocyte chemotactic peptide-1 in renal transplant recipients with polyomavirus replication.
Boratyńska M; Dubiński B; Rybka K; Jezior D; Szyber P; Klinger M
Transplant Proc; 2006; 38(1):151-4. PubMed ID: 16504689
[TBL] [Abstract][Full Text] [Related]
18. Prediction of subclinical renal allograft rejection by vascular endothelial growth factor in serum and urine.
Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
J Nephrol; 2008; 21(4):535-42. PubMed ID: 18651543
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
[TBL] [Abstract][Full Text] [Related]
20. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
